本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cardiol Therapeutics Inc

1.86
0.0000
盤前1.900.0400+2.15%05:02 EDT
成交量:101.18萬
成交額:183.20萬
市值:2.17億
市盈率:-7.88
高:1.88
開:1.88
低:1.76
收:1.86
52周最高:2.00
52周最低:0.8800
股本:1.17億
流通股本:9,805.55萬
量比:0.64
換手率:1.03%
股息:- -
股息率:- -
每股收益(TTM):-0.2360
每股收益(LYR):-0.2835
淨資產收益率:-190.18%
總資產收益率:-90.92%
市淨率:12.53
市盈率(LYR):-6.56

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/31

年度報告

Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2025/04/01

年度報告

Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2024/11/06

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/04/01

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/03/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/04/20

[修訂]年度報告

40-F/A [Amend] - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2022/03/24

年度報告

40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2022/02/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/18

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/18

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/11/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/19

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans